Originally published In Press as doi:10.1074/jbc.M311838200 on April 16, 2004
J. Biol. Chem., Vol. 279, Issue 26, 26991-27007, June 25, 2004
CD44 Interaction with Na+-H+ Exchanger (NHE1) Creates Acidic Microenvironments Leading to Hyaluronidase-2 and Cathepsin B Activation and Breast Tumor Cell Invasion*
Lilly Y. W. Bourguignon
,
Patrick A. Singleton,
Falko Diedrich,
Robert Stern¶, and
Eli Gilad
From the
Department of Medicine, University of California, and Endocrine Unit, Veterans Affairs Medical Center and the ¶Department of Pathology, University of California, San Francisco, California 94121
We have explored CD44 (a hyaluronan (HA) receptor) interaction with a Na+-H+ exchanger (NHE1) and hyaluronidase-2 (Hyal-2) during HA-induced cellular signaling in human breast tumor cells (MDA-MB-231 cell line). Immunological analyses demonstrate that CD44s (standard form) and two signaling molecules (NHE1 and Hyal-2) are closely associated in a complex in MDA-MB-231 cells. These three proteins are also significantly enriched in cholesterol and ganglioside-containing lipid rafts, characterized as caveolin and flotillin-rich plasma membrane microdomains. The binding of HA to CD44 activates Na+-H+ exchange activity which, in turn, promotes intracellular acidification and creates an acidic extracellular matrix environment. This leads to Hyal-2-mediated HA catabolism, HA modification, and cysteine proteinase (cathepsin B) activation resulting in breast tumor cell invasion. In addition, we have observed the following: (i) HA/CD44-activated Rho kinase (ROK) mediates NHE1 phosphorylation and activity, and (ii) inhibition of ROK or NHE1 activity (by treating cells with a ROK inhibitor, Y27632, or NHE1 blocker, S-(N-ethyl-N-isopropyl) amiloride, respectively) blocks NHE1 phosphorylation/Na+-H+ exchange activity, reduces intracellular acidification, eliminates the acidic environment in the extracellular matrix, and suppresses breast tumor-specific behaviors (e.g. Hyal-2-mediated HA modification, cathepsin B activation, and tumor cell invasion). Finally, down-regulation of CD44 or Hyal-2 expression (by treating cells with CD44 or Hyal-2-specific small interfering RNAs) not only inhibits HA-mediated CD44 signaling (e.g. ROK-mediated Na+-H+ exchanger reaction and cellular pH changes) but also impairs oncogenic events (e.g. Hyal-2 activity, hyaluronan modification, cathepsin B activation, and tumor cell invasion). Taken together, our results suggest that CD44 interaction with a ROK-activated NHE1 (a Na+-H+ exchanger) in cholesterol/ganglioside-containing lipid rafts plays a pivotal role in promoting intracellular/extracellular acidification required for Hyal-2 and cysteine proteinase-mediated matrix degradation and breast cancer progression.
Received for publication, October 29, 2003
, and in revised form, April 15, 2004.
* This work was supported by United States Public Health Grants R01 CA66163, R01 CA 78633, and P01 AR39448 from the National Institutes of Health and a Veterans Affairs Merit Review grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence and reprint requests should be addressed: Endocrine Unit (111N), Dept. of Medicine, University of California, San Francisco, and Veterans Affairs Medical Center, 4150 Clement St., San Francisco, CA 94121. Tel.: 415-221-4810 (Ext. 3321); Fax: 415-383-1638; E-mail: lillyb{at}itsa.ucsf.edu.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K. N. Sugahara, T. Hirata, T. Tanaka, S. Ogino, M. Takeda, H. Terasawa, I. Shimada, J.-i. Tamura, G. B. ten Dam, T. H. van Kuppevelt, et al.
Chondroitin Sulfate E Fragments Enhance CD44 Cleavage and CD44-Dependent Motility in Tumor Cells
Cancer Res.,
September 1, 2008;
68(17):
7191 - 7199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. C. Martin, V. Atmuri, R. J. Hemming, J. Farley, J. S. Mort, S. Byers, S. Hombach-Klonisch, R. Stern, and B. L. Triggs-Raine
A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis
Hum. Mol. Genet.,
July 1, 2008;
17(13):
1904 - 1915.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gillies, I. Robey, and R. A. Gatenby
Causes and Consequences of Increased Glucose Metabolism of Cancers
J. Nucl. Med.,
June 1, 2008;
49(Suppl_2):
24S - 42S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Hemming, D. C. Martin, E. Slominski, J. I. Nagy, A. J. Halayko, S. Pind, and B. Triggs-Raine
Mouse Hyal3 encodes a 45- to 56-kDa glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells
Glycobiology,
April 1, 2008;
18(4):
280 - 289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. L. Wu, H. Miao, and S. Khan
JAK kinases promote invasiveness in VHL-mediated renal cell carcinoma by a suppressor of cytokine signaling-regulated, HIF-independent mechanism
Am J Physiol Renal Physiol,
December 1, 2007;
293(6):
F1836 - F1846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Singleton, R. Salgia, L. Moreno-Vinasco, J. Moitra, S. Sammani, T. Mirzapoiazova, and J. G. N. Garcia
CD44 Regulates Hepatocyte Growth Factor-mediated Vascular Integrity: ROLE OF c-Met, Tiam1/Rac1, DYNAMIN 2, AND CORTACTIN
J. Biol. Chem.,
October 19, 2007;
282(42):
30643 - 30657.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. Bharadwaj, K. Rector, and M. A. Simpson
Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis
J. Biol. Chem.,
July 13, 2007;
282(28):
20561 - 20572.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Y. W. Bourguignon, E. Gilad, and K. Peyrollier
Heregulin-mediated ErbB2-ERK Signaling Activates Hyaluronan Synthases Leading to CD44-dependent Ovarian Tumor Cell Growth and Migration
J. Biol. Chem.,
July 6, 2007;
282(27):
19426 - 19441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Vigdorovich, A. D. Miller, and R. K. Strong
Ability of Hyaluronidase 2 To Degrade Extracellular Hyaluronan Is Not Required for Its Function as a Receptor for Jaagsiekte Sheep Retrovirus
J. Virol.,
April 1, 2007;
81(7):
3124 - 3129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Harada and M. Takahashi
CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2
J. Biol. Chem.,
February 23, 2007;
282(8):
5597 - 5607.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Piwnica, I. Fernandez, N. Binart, P. Touraine, P. A. Kelly, and V. Goffin
A New Mechanism for Prolactin Processing into 16K PRL by Secreted Cathepsin D
Mol. Endocrinol.,
December 1, 2006;
20(12):
3263 - 3278.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Misra, B. P. Toole, and S. Ghatak
Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells
J. Biol. Chem.,
November 17, 2006;
281(46):
34936 - 34941.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Thankamony and W. Knudson
Acylation of CD44 and Its Association with Lipid Rafts Are Required for Receptor and Hyaluronan Endocytosis
J. Biol. Chem.,
November 10, 2006;
281(45):
34601 - 34609.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Singleton, S. M. Dudek, S.-F. Ma, and J. G. N. Garcia
Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation: NOVEL ROLE FOR HYALURONAN AND CD44 RECEPTOR FAMILY
J. Biol. Chem.,
November 10, 2006;
281(45):
34381 - 34393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Sarnataro, S. Pisanti, A. Santoro, P. Gazzerro, A. M. Malfitano, C. Laezza, and M. Bifulco
The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism
Mol. Pharmacol.,
October 1, 2006;
70(4):
1298 - 1306.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. N. Sugahara, T. Hirata, H. Hayasaka, R. Stern, T. Murai, and M. Miyasaka
Tumor Cells Enhance Their Own CD44 Cleavage and Motility by Generating Hyaluronan Fragments
J. Biol. Chem.,
March 3, 2006;
281(9):
5861 - 5868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Tzircotis, R. F. Thorne, and C. M. Isacke
Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding
J. Cell Sci.,
November 1, 2005;
118(21):
5119 - 5128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Chow and W. Knudson
Characterization of Promoter Elements of the Human HYAL-2 Gene
J. Biol. Chem.,
July 22, 2005;
280(29):
26904 - 26912.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Udabage, G. R. Brownlee, M. Waltham, T. Blick, E. C. Walker, P. Heldin, S. K. Nilsson, E. W. Thompson, and T. J. Brown
Antisense-Mediated Suppression of Hyaluronan Synthase 2 Inhibits the Tumorigenesis and Progression of Breast Cancer
Cancer Res.,
July 15, 2005;
65(14):
6139 - 6150.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Cardone, A. Bagorda, A. Bellizzi, G. Busco, L. Guerra, A. Paradiso, V. Casavola, M. Zaccolo, and S. J. Reshkin
Protein Kinase A Gating of a Pseudopodial-located RhoA/ROCK/p38/NHE1 Signal Module Regulates Invasion in Breast Cancer Cell Lines
Mol. Biol. Cell,
July 1, 2005;
16(7):
3117 - 3127.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Misra, S. Ghatak, and B. P. Toole
Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2
J. Biol. Chem.,
May 27, 2005;
280(21):
20310 - 20315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Y. W. Bourguignon, E. Gilad, K. Rothman, and K. Peyrollier
Hyaluronan-CD44 Interaction with IQGAP1 Promotes Cdc42 and ERK Signaling, Leading to Actin Binding, Elk-1/Estrogen Receptor Transcriptional Activation, and Ovarian Cancer Progression
J. Biol. Chem.,
March 25, 2005;
280(12):
11961 - 11972.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ghatak, S. Misra, and B. P. Toole
Hyaluronan Constitutively Regulates ErbB2 Phosphorylation and Signaling Complex Formation in Carcinoma Cells
J. Biol. Chem.,
March 11, 2005;
280(10):
8875 - 8883.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Jenkins, G. J. Thomas, J. D. Williams, and R. Steadman
Myofibroblastic Differentiation Leads to Hyaluronan Accumulation through Reduced Hyaluronan Turnover
J. Biol. Chem.,
October 1, 2004;
279(40):
41453 - 41460.
[Abstract]
[Full Text]
[PDF]
|
|
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
